Strutt Day also celebrated early industry recognition. The ev (1) has already earned the only 2025 Red Dot: Luminary for design excellence, and received the 2026 CES Best of Innovation award for ...

Upwind, the next generation runtime-first cloud security leader, today announced the launch of its integrated AI security suite, expanding the company's CNAPP to protect the rapidly growing enterprise ...

You can create a release to package software, along with release notes and links to binary files, for other people to use. Learn more about releases in our docs.

You can create a release to package software, along with release notes and links to binary files, for other people to use. Learn more about releases in our docs.

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has been ...

Vertex Pharma could be close to succeeding in the long-standing quest to find an alternative to potentially addictive opioids for the treatment of pain associated with common medical procedures.

Robots may not be taking the place of researchers in lab coats running clinical trials anytime soon, but AI is playing an increasingly important role in drug discovery efforts. That’s the message ...

It's a good idea to go against the current market sentiment on this one. Vertex Pharmaceuticals continues to generate most of its revenue from its cystic fibrosis (CF) franchise. The company's ...

Vertex Pharmaceuticals recently presented updated interim data at the 2025 ASN Kidney Week, revealing significant proteinuria reductions and eGFR stabilization with povetacicept in patients with IgA ...

Lester remembers that he took several guitars along to the session so that songwriters/producers Matt Rowe and Richard ...

News headlines Vertex Pharmaceuticals (VRTX) is experiencing notable momentum with revised analyst estimates and a focus on its expanding pipeline. Recent performance has shown a 9.2% increase over ...